References
- Kohli K, Ali J, Ansari MJ, Raheman Z. Curcumin: a natural antiinflammatory agent. Indian J Pharmacol 2005;37:141–7
- Anand P, Thomas SG, Kunnumakkara AB, et al. Biological activities of curcumin and its analogues (congeners) made by man and mother nature. Biochem Pharmacol 2008;76:1590–611
- Jurenka JS. Anti-infammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev 2009;14:141–53
- Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003;23:363–98
- Pan MH, Huang TM, Lin JK. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 1999;27:486–94
- Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today 2012;17:71–80
- Delmas T, Piraux H, Couffin AC, et al. How to prepare and stabilize very small nanoemulsion. Langmuir 2011;27:1683–92
- Wang X, Jiang Y, Wang YW, et al. Enhancing anti-inflammation activity of curcumin through o/w nanoemulsion. Food Chem 2008;108:419–24
- Sharma S, Parwa S, Jain UK. Development and evaluation of topical gel of curcumin from different combination of polymers formulation & evaluation of herbal gel. Int J Pharm Pharm Sci 2012;4:452–6
- Rachmawati H, Edityaningrum CA, Mauludin R. Molecular inclusion complex of curcumin-β-cyclodextrin nanoparticle to enhance curcumin skin permeability from hydrophilic matrix gel. AAPS PharmSciTech 2013;14:1303–12
- Tay SLM, Heng PWS, Chan LW. An investigation of the chick chorioallantoic membrane as an alternative model to various biological tissues for permeation studies. J Pharm Pharmacol 2011;63:1283–9
- Haigh JM, Beyssac E, Chanet L, Aiache JM. In vitro permeation of progesterone from a gel through the shed skin of three different snake species. Int J Pharm 1998;170:151–6
- Chien YW. Novel drug delivery systems. 2nd ed. London: Marcel Dekker; 1992
- Date AA, Nagarsenker MS. Parenteral microemulsions: an overview. Int J Pharm 2008;355:19–30
- Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipient. 6th ed. London: Pharmaceutical Press and American Pharmacist Association; 2009
- Zhang L, Zhu W, Yang C, et al. A novel folate-modified self-microemulsfying drug delivery system of curcumin for colon targeting. Int J Nanomed 2012;7:151–62
- Mohan PRK, Sreelakshmi G, Muraleedharan CV, Joseph R. Water soluble complexes of curcumin with cyclodextrins: characterization by FT-Raman spectroscopy. Vib Spectros 2012;62:77–84
- Park HJ, Kong M. Stability investigation of hyaluronic acid based nanoemulsion and its potential as transdermal carrier. Carbohydr Polym 2011;83:1303–10
- Harwansh RK, Patra KC, Pareta SK, et al. Nanoemulsion as vehicles for transdermal delivery of glycyrrhizin. Brazilian J Pharm Sci 2011;47:769–78
- Paudel KS, Milewski M, Swadley CL, et al. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv 2010;1:109–31
- Azeem A, Ahmad FJ, Khar RK, Talegaonkar S. Nanocarrier for the transdermal delivery of antiparkinsonian drug. AAPS PharmSciTech 2009;10:1093–103
- Ledet G, Pamujula S, Walker V, et al. Development and in vitro evaluation of a nanoemulsion for transcutaneous delivery. Drug Dev Ind Pharm 2013. [Epub ahead of print]. doi:10.3109/03639045.2012.763137
- Hussain A, Samad A, Nazish I, Ahmed FJ. Nanocarrier-based topical drug delivery for an antifungal drug. Drug Dev Ind Pharm 2013. [Epub ahead of print]. doi:10.3109/03639045.2013.771647
- Dash S, Murthy PN, Nath L. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm 2010;67:217–23
- Verma PRP, Chandak AR. Development of matrix controlled transdermal delivery systems of pentazocine: in vitro/in vivo perfomance. Acta Pharm 2009;59:171–86